FRIDAY 13.09.2024
| 09:00 – 09:15 | Opening remarks | P. Gastoł |
| 09:15 – 09:45 | Lecture of art | |
| PREDICT trial. Will it change our management on VUR and how? | G. Montini | |
| 09:45 – 10:00 | Discussion | |
| 10:00 – 10:15 | Coffee brake | |
| 10:15 – 12.15 | Session I – DIAGNOSIS | B. Burgu P. Gastoł |
| 10:15 – 10:45 | Embryology and anatomy of the ureterovesical junction | Ch. Radmayr |
| 10:45 – 11:15 | Prenatal and postnatal diagnosis of VUR | S. Tekgül |
| 11:15 – 11:25 | Discussion | |
| 11:15 – 11:25 | Presentations and Discussion | |
| Vesicoureteral reflux in cystourethrography – one picture, two points of view. M. Plewko, D. Majak, K. Felberg, M. Gogolewski, G. Grochowska, K. Oskroba, K. Kowalczyk, L. Włodarska-Skobejko, K. Strulak, P. Gastoł | ||
| Analysis of clinical scenarios in which voiding cystourethrography has impact on urological approach compared to cases in which it is merely redundant A. Jędzura, P. Wysocka-Wojakiewicz, P. Adamczyk, A. Wiernik, G. Kudela, T. Koszutski | ||
| Primary vesico-ureteral reflux in female neonates – changes in US, grade, kidney damage and associated anomalies in the urinary tract. B. Cuch, K. Pomorska, K. Kowalczyk, P. Gastoł | ||
| Primary vesico-ureteral reflux in male neonates – changes in US, grade, kidney damage and associated anomalies in the urinary tract. K. Pomorska, B. Cuch, K. Kowalczyk, P. Gastoł | ||
| Assessment of lower urinary tract symptoms in paediatric population with overweight and obesity. A. Piotrowska-Gall, M. Wójcik, A. Cygan, E. Szczudlik, A. Stępniewska, B. Dobrowolska-Glazar, R. Chrzan | ||
| 12:15 – 12:45 | The primary hyperoxalurias – diagnosis and treatment Sponsor lecture Medison Pharma | Y. Frishberg |
| 12:45- 13:45 | Lunch | |
| 13:45 – 16:00 | Session II – CLINICAL CORRELATION | Ch. Radmayr R. Chrzan |
| 13:45 – 14:15 | Role of bladder dysfunction in VUR | B. Burgu |
| 14:15 – 14:25 | Discussion | |
| 14:25 – 14:55 | Neurogenic bladder dysfunction and VUR | S. Tekgül |
| 14:55 – 15:05 | Discussion | |
| 15:05 – 16:00 | Presentations and Discussion | |
| The patients with neurogenic bladder, severe bones deformities and chronic renal failure – preparation for future kidney transplantation. L. Skobejko-Włodarska, K. Kowalczyk | ||
| Vesicoureteral reflux in children with classic bladder exstrophy. G. Grochowska, K. Felberg, P. Gastoł, Sz.Wilk | ||
| Vesicoureteral reflux secondary to ureterocele treatment in duplex system. G. Grochowska, K. Felberg, P. Gastoł | ||
| Vesicoureteral reflux – challenge in patients prepared for kidney transplant M. Gogolewski | ||
| Congenital obstructive megaureter: a case presentation and review of literature. M. Wolnicki, B. Dobrowolska-Glazar, I. Honkisz, J. Sulisławski, R. Chrzan | ||
| 16:00 – 16:20 | Patient on CIC – guidelines for children and adults Sponsor lecture: Coloplast | K. Felberg |
| 16:30 – 17:30 | PAPU General Assembly | |
| 19:00 | Dinner |
SATURDAY 14.09.2024
| 08:45 – 10:05 | Session III – CONSEQUENCES | S. Tekgül K. Felberg | |
| 08:45 – 09:15 | Reflux nephropathy (VUR from pediatric nephrologists point of view) | M. Litwin | |
| 09:15 – 09:45 | Reflux consequences in adult life | Ł. Obrycki | |
| 09:45 – 09:55 | Discussion | ||
| 09:55 – 10:05 | Presentations and Discussion | ||
| Do vesico-ureteral reflux operations damage male fertility – an andrologist’s view. J. K. Wolski, A. Sobczyńska-Tomaszewska, J. Ostrowska | |||
| 10:05 – 10:20 | CAUTI- strategia bez antybiotyku Sponsor lecture: BBraun | P. Dalkowski | |
| 10:20 – 10:30 | Coffee brake | ||
| 10:30 – 14:10 | Session IV – TREATMENT | W. Apoznański T. Koszutski | |
| 10:30 – 10:45 | The ceremonial awarding of the Title of the Honorary Member of the Polish Association for Paediatric Urology | ||
| 10:45 – 11:15 | Open surgery in VUR | K. Felberg | |
| 11:15 – 11:45 | Endoscopic treatment of VUR | B. Burgu | |
| 11:45 – 12:15 | Robotic assisted and laparoscopic treatment of VUR | R. Chrzan | |
| 12:15 – 12:30 | Discussion | ||
| 12:30 – 14:10 | Presentations and Discussion | ||
| Blocksom vesicostomy in vesico-ureteral reflux treatment. K. Oskroba, A. Bilicka, K. Kowalczyk, P. Gastoł | |||
| The consequences of uretral reimplantation in infants. B. Dobrowolska-Glazar, I. Honkisz, J. Sulisławski, A. Piotrowska-Gall, M. Wolnicki, R. Chrzan | |||
| Difficulties in endourological procedures after antireflux ureter transplantation due to VUR. A. Haliński, P. Haliński, A. Haliński | |||
| Efficiency of Endoscopic Injection for the Correction of Vesicoureteral Reflux M.A. Ardelean, P. Gombos, M.G. Brandtner, C. Schimke, R. Metzger | |||
| Intraoperative and prospective urosonography in children with vesicoureteral reflux treated endoscopically P. Osemlak, J. Biernat-Michno, P. Nachulewicz, M. Woźniak | |||
| Application of non-absorbable medication in the treatment of VUR. Single-center study. Years 2020-2023. J. Samotyjek, E. Wajszczuk, B. Jurkiewicz, J. Litewka, K. Załęska-Oracka | |||
| Complications associated with endoscopic treatment of vesicoureteral reflux. K. Standio-Pomorska, L. Skobejko-Włodarska, K. Felberg, K. Kowalczyk, P. Gastoł | |||
| Endoscopic injection of PPC (polyacrylate polyalcohol copolymer) in the long term follow-up. Should we really be worried? J. Czyż | |||
| Late-onset ureteral obstruction after use of polyacrylate-polyalcohol copolymer (PPC) for endoscopic treatment of vesicoureteral reflux in children. R. Mackiewicz, S. Anzelewicz, M. Osajca, A. Gołębiewski | |||
| Congenital kidney malformations and vesicoureteral reflux in patients with persistent cloaca. A, Bilicka, K. Felberg, P. Gastoł | |||
| 14:10 | Closing remarks | P. Gastoł | |
| Lunch |